Characterization of microvesicles in B-Cell chronic lymphocytic leukemia (CLL): A potential mediator in CLL B cell disease progression?

被引：0
|
作者：
Ghosh, Asish K. [1 ]
Kay, Neil E. [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.747.747
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
747
引用
收藏
页码：230A / 230A
页数：1
相关论文
共 50 条
  • [31] Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Chronic Lymphocytic Leukemia (CLL) Driver Genes: Risk of CLL and Monoclonal B-Cell Lymphocytosis (MBL)
    Boddicker, Nicholas J.
    O'Brien, Daniel R.
    Braggio, Esteban
    Achenbach, Sara J.
    Chaffee, Kari G.
    Norman, Aaron D.
    Vachon, Celine M.
    Kabat, Brian
    Call, Timothy G.
    Parikh, Sameer A.
    Leis, Jose F.
    Ding, Wei
    Muchtar, Eli
    Cerhan, James R.
    Shanafelt, Tait D.
    Kay, Neil E.
    Caporaso, Neil E.
    Slager, Susan L.
    BLOOD, 2018, 132
  • [32] Plasma levels of vascular endothelial growth factor (VEGF) are predictive of disease-progression in B-cell chronic lymphocytic leukemia (B-CLL).
    Maurillo, L
    Del Poeta, G
    Venditti, A
    Giovanna, S
    Buccisano, F
    Del Principe, MI
    Tamburini, A
    Scornajenghi, A
    Epiceno, AM
    Piccioni, D
    Amadori, S
    BLOOD, 2001, 98 (11) : 360A - 360A
  • [33] Spontaneous apoptosis and proliferation predict disease progression within ZAP-70 negative B-cell chronic lymphocytic leukemia (B-CLL)
    Del Poeta, G
    Del Principe, MI
    Niscola, P
    Maurillo, L
    Venditti, A
    Buccisano, F
    Consalvo, MI
    Mazzone, C
    Panetta, P
    Degan, M
    Pasqua, I
    Bruno, A
    Gattei, V
    Lo Coco, F
    Amadori, S
    BLOOD, 2005, 106 (11) : 349A - 349A
  • [34] CYTOGENETIC FINDINGS IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - A PROGRESS REPORT
    HAN, T
    EMRICH, L
    SADAMORI, N
    OTAKI, K
    BLOCK, AW
    GOMEZ, GA
    OZER, H
    HENDERSON, ES
    BLOOM, ML
    SANDBERG, AA
    EXPERIMENTAL HEMATOLOGY, 1986, 14 (06) : 535 - 535
  • [35] Management of chronic lymphocytic leukemia (CLL) in the era of B-cell receptor signal transduction inhibitors
    Mato, Anthony
    Jauhari, Shekeab
    Schuster, Stephen J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (07) : 657 - 664
  • [36] Increased stability of bcl-2 mRNA in B-cell chronic lymphocytic leukemia (CLL).
    Kio, EA
    Pineda-Roman, M
    Otake, Y
    Stuart, RK
    Fernandes, DJ
    BLOOD, 2004, 104 (11) : 280B - 280B
  • [37] Monoclonal B-cell lymphocytosis (MBL) is a precursor state for chronic lymphocytic leukemia (CLL) with 1% progression per year
    Rawstron, Andy C.
    Bennet, Fiona L.
    O'Connor, Sheila J. M.
    Kwok, Marwan
    Fenton, James A. L.
    Plummer, Marieth
    de Tute, Ruth M.
    Owen, Roger G.
    Richards, Stephen J.
    Jack, Andrew S.
    Hillmen, Peter
    BLOOD, 2007, 110 (11) : 230A - 231A
  • [38] Evidence for abnormal angiogenesis in the bone marrow of patients with B-cell chronic lymphocytic leukemia (CLL).
    Kini, AR
    Peterson, LC
    Kay, NE
    BLOOD, 1998, 92 (10) : 717A - 717A
  • [39] RUXOLITINIB INDUCES APOPTOSIS OF B-CELL RECEPTOR STIMULATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) CELLS
    Rozovski, U.
    Wu, J. Yuan
    Harris, D.
    Liu, Z.
    Li, P.
    Hazan-Halevi, I.
    Ferrajoli, A.
    Burger, J.
    O'brien, S.
    Wierda, W.
    Keating, M.
    Estrov, Z.
    HAEMATOLOGICA, 2014, 99 : 38 - 38
  • [40] Prognostic significance of Zap-70 expression in B-cell chronic lymphocytic leukemia (CLL).
    Kowal, M
    Dmoszynska, A
    Bojarska-Junak, A
    Rolinski, J
    Wawrzaszek, P
    BLOOD, 2003, 102 (11) : 349B - 350B
12345